Isolation, speciation, and antibiogram of clinically relevant non-diphtherial Corynebacteria (Diphtheroids)

Indian Journal of Medical Microbiology
B S ReddyB V Ramana

Abstract

Coryneform or the non-diphtherial Corynebacterium species largely remains a neglected group with the traditional consideration of these organisms as contaminants. This concept, however, is slowly changing in the light of recent observations. This study has been done to find out the species distribution and antibiogram of various members of the clinically relevant Coryneform group, isolated from various clinical materials. One hundred and fourteen non-duplicate isolates of diphtheroids from various clinical isolates were selected for the study. The isolates were identified to the species level by using a battery of tests; and antimicrobial susceptibility was tested by using a combination of Clinical and Laboratory Standards Institute (CLSI) and the British Society for Antimicrobial Chemotherapy (BSAC) guidelines, in the absence of definitive CLSI guidelines. Corynebacterium amycolatum was the predominant species (35.9%) in our series followed by the CDC Group G organisms (15.7%). Each of the remaining 19 species comprised of less than 10% of the isolates. More than half the total isolates were resistant to the penicillins, erythromycin, and clindamycin; while excellent activity (all the strains being susceptible) was shown by va...Continue Reading

References

Oct 1, 1991·Antimicrobial Agents and Chemotherapy·J A García-RodriguezI García García
Dec 1, 1990·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·A Philippon, F Bimet
Jan 1, 1997·Clinical Microbiology Reviews·G FunkeK A Bernard
Dec 1, 1996·Antimicrobial Agents and Chemotherapy·G FunkeA von Graevenitz
Jul 10, 2009·The Journal of Antimicrobial Chemotherapy·J M Andrews, UNKNOWN BSAC Working Party on Susceptibility Testing
Dec 25, 2009·Journal of Clinical Microbiology·Jenny S J WongDavid R Murdoch
Dec 2, 2010·Journal of Cancer Research and Therapeutics·Meena DiasDinesh Shet

❮ Previous
Next ❯

Citations

Apr 17, 2014·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Magdalena SzemrajEligia M Szewczyk
Mar 26, 2013·International Journal of Cardiology·Asha TharayilMichael W Bungo
Oct 12, 2018·Journal of Clinical Microbiology·Fabian KaltYvonne Achermann
Jul 18, 2018·Polish Journal of Microbiology·Magdalena SzemrajEligia M Szewczyk
Dec 16, 2020·BMJ Case Reports·Radha SugumaranAmit Kumar Deb
Feb 25, 2020·Infectious Disorders Drug Targets·Priya DattaJagdish Chander

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

© 2022 Meta ULC. All rights reserved